Your browser doesn't support javascript.
loading
CIITA expression is regulated by histone deacetylase enzymes and has a role in α-synuclein pre-formed fibril-induced antigen presentation in murine microglial cell line.
Günaydin, Caner; Çelik, Z Betül; Bilge, S Sirri.
Afiliação
  • Günaydin C; Department of Pharmacology, School of Medicine, Samsun University, Samsun, Turkey.
  • Çelik ZB; Department of Histology and Embryology, School of Medicine, Ondokuz Mayis University, Samsun, Turkey.
  • Bilge SS; Department of Pharmacology, School of Medicine, Ondokuz Mayis University, Samsun, Turkey.
Immunopharmacol Immunotoxicol ; 44(3): 447-455, 2022 Jun.
Article em En | MEDLINE | ID: mdl-35291899
ABSTRACT

AIM:

Parkinson's disease (PD) is a chronic neurodegenerative disorder related with several genetic and epigenetic factors. In the context of epigenetic factors, histone acetylation is one of the most associated mechanisms with Parkinson's disease progression. This study investigates the effects of the increased histone acetylation on antigen presentation in microglial cells which were induced by pre-formed fibrils of α-synuclein (pFF α-synuclein).

METHODS:

Parkinson's disease model was created with pFF α-synuclein administration to the BV-2 microglial cells. BV-2 cells were co-treated with CUDC-907 and TMP-195 to increase histone acetylation in the presence of α-synuclein. Antigen representation was evaluated by determining expression levels of major histocompatibility complex-II (MHC-II) and class-II major histocompatibility complex (CIITA).

RESULTS:

Our results showed that pFF α-synuclein significantly increased MHC-II expression, and that effect was most severe at 6 h of administration of α-synuclein. Increasing histone acetylation via CUDC-907 and TMP-195 enhanced MHC-II levels expression, which was more severe in CUDC-907. Additionally, CIITA expression levels were significantly increased with pFF α-synuclein administration and intensified with the co-treatment of CUDC-907 and TMP-195. Furthermore, pFF α-synuclein caused a time-dependent increase in the IFN-gamma (IFN-É£) and interleukin-16(IL-16) levels, and that increase was potentiated with CUDC-907 and TMP-195.

CONCLUSION:

Changes in MHC-II and CIITA expression indicate that histone acetylation increases the antigen presentation properties of microglial cells after pFF α-synuclein or histone deacetylase inhibitor (HDACi) administration. Our results show that microglial antigen presentation might have an essential role in the pathology of Parkinson's disease, and α-synuclein likely to play a primary role in this mechanism.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Parkinson / Proteínas Nucleares / Transativadores / Alfa-Sinucleína Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Immunopharmacol Immunotoxicol Assunto da revista: ALERGIA E IMUNOLOGIA / FARMACOLOGIA / TOXICOLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Turquia

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Parkinson / Proteínas Nucleares / Transativadores / Alfa-Sinucleína Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Immunopharmacol Immunotoxicol Assunto da revista: ALERGIA E IMUNOLOGIA / FARMACOLOGIA / TOXICOLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Turquia